此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

The Role of Visual Attention and Environmental Complexity in Real-world Mobility for People With Lower Limb Amputation

2026年9月17日 更新者:Virginia Commonwealth University

Despite high medical expenses (>$500K/patient), mobility improvements achieved during rehabilitation for people with lower limb amputation (LLA) fail to translate into improved real-world outcomes. Even with advances in prosthesis technology enabling faster gait speed, greater walking endurance, and improved mobility confidence, people with LLA report persistent dissatisfaction with real-world mobility, limited ability to walk in the community, and difficulty achieving recommended physical activity levels.

Real-world walking requires thinking and moving simultaneously (e.g., cognitive-motor dual-tasking), visually attending to the environment, and navigating varying terrain. In contrast, clinical mobility assessments are usually performed without additional visual or cognitive demands, in controlled environments, and on level surfaces. Current clinical tools used to assess ambulation progression during rehabilitation do not adequately assess these changes in people who have experienced LLA.

研究概览

详细说明

A step toward rectifying a critical gap in care for those with LLA by quantifying the effect of vision-based and non-vision-based cognitive-motor dual-tasking and high and low complexity terrain on gait speed and gaze behavior. Cognitive-motor dual-task assessment paradigms are well-established in other populations and often used to better approximate real-world walking demands. However, the type of cognitive task used is an important factor. The most common methods for dual-task assessment in people with LLA are limited to cognitive tasks lacking overt visual attention (e.g., serial subtraction - performing repeated subtractions from a given starting number).Although walking while performing non-vision-based cognitive tasks results in slower gait speed than single-task walking, this type of task has limited ecological validity and the observed dual-task performances have not been associated with real-world walking outcomes.

Performing vision-based cognitive-motor dual-tasks is particularly important for people with LLA. Due to lost somatosensory input from the amputated limb, the central nervous system increases dependence on visual input for sensorimotor integration. As a result, people with LLA report needing to "concentrate on every step", and affix their gaze on each subsequent step compared to 3 steps ahead like adults without LLA.

Current clinical assessments fail to detect impairments during mobility tasks requiring visual attention in complex environments. The lack of understanding of the interaction between visual attention and complex environment precludes a comprehensive mobility assessment, allows undetected impairments to persist, and limits translation of rehabilitation gains into improved real-world mobility outcomes.

研究类型

观察性的

注册 (估计的)

30

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:Paul Kline
  • 电话号码:804-828-4483
  • 邮箱:klinep@vcu.edu

学习地点

    • Virginia
      • Richmond、Virginia、美国、23239
        • 招聘中
        • Virginia Commonwealth University
        • 接触:
        • 首席研究员:
          • Paul Kline

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

概率样本

研究人群

We will compare gait speed (Aim1) and gaze behavior with eye-tracking glasses (Aim 2) during vision-based (visual puzzles) and non-vision-based (serial subtraction) cognitive-motor dual-tasking while walking on low and high complexity terrain in people with LLA (n=20) and matched controls (n=10).

描述

Inclusion Criteria:

  • unilateral transtibial LLA of either dysvascular (diabetes, peripheral vascular disease, and/or infection) or traumatic etiology
  • 18 years old minimum
  • able to ambulate 2 minutes without rest
  • 9 months since LLA
  • fitted with terminal prosthesis
  • 20/60 vision or better (with or without glasses/contacts)

Exclusion Criteria:

  • congenital or cancer-related LLA
  • ankle-level or above LLA on the contralateral limb
  • residual limb wound or contralateral foot ulcer
  • unstable heart condition (including unstable angina, uncontrolled cardiac dysrhythmia, acute myocarditis, hypertension, and acute pericarditis)
  • acute systemic infection
  • prisoner
  • inability to follow a 3-step command
  • concussion/brain injury in the past 12 months
  • active cancer treatment
  • preexisting neurological condition (i.e., multiple sclerosis, Parkinson's disease)
  • participating in prosthetic rehabilitation
  • color-blindness
  • history of seizure(s)
  • inability to read and communicate in English.

Participants in the control group must meet the non-amputation-related criteria noted above, be within ±2 years and the same biological sex as their paired participants with LLA.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:COHORT
  • 时间观点:PROSPECTIVE

队列和干预

团体/队列
干预/治疗
Subjects with Lower Limb Amputation (LLA)

20 participants with below knee amputation.

Assessment of accelerometry: Daily duration (minutes) of sitting, standing, stepping, Daily step count, Daily walking bouts stepping cadence, Timed Up and Go and Two-minute Walk Test

Comprehensive assessment of eye movements during walking including Target Fixation Time (seconds; %) and Number of fixations

The following assessments will be completed: World health organization disability assessment schedule 2.0 (WHODAS), and Activities Specific Balance Confidence Scale.

Matched Control

10 sex- and age-matched control participants.

Assessment of accelerometry: Daily duration (minutes) of sitting, standing, stepping, Daily step count, Daily walking bouts stepping cadence, Timed Up and Go and Two-minute Walk Test

Comprehensive assessment of eye movements during walking including Target Fixation Time (seconds; %) and Number of fixations

The following assessments will be completed: World health organization disability assessment schedule 2.0 (WHODAS), and Activities Specific Balance Confidence Scale.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Gait Analysis-Walking Speed
大体时间:Visit 1 and visit 2 (which will take place 10-14 days after visit 1)

Measure walking speed meters/second. Captured during dual-task and single-task walking, it is used to measure motor performance. Normal Speed: Healthy adults usually walk at 1.2 to 1.4 meters per second.Fall Risk: A speed below 1.0 meter per second shows a higher risk for falls.Frailty Warning: A speed below 0.6 to 0.8 meters per second suggests a high risk of functional decline or disability.

Visit 1 and visit 2 (which will take place 10-14 days after visit 1)
Gait Analysis-Stride Length
大体时间:Visit 1 and visit 2 (which will take place 10-14 days after visit 1)

Measure the stride length in meters. stride length is the total distance covered during one full cycle of walking or running with the same foot. It measures the space from where one foot touches the ground to when that exact same foot touches the ground again.

Visit 1 and visit 2 (which will take place 10-14 days after visit 1)
Gait Analysis-Stride length asymmetry
大体时间:Visit 1 and visit 2 (which will take place 10-14 days after visit 1)

Assess Stride length asymmetry is an imbalance where the distance covered by the right and left steps differs. Symmetry Index (SI): Compares spatial step metrics or temporal single-limb support times between limbs.Percentage difference: Calculated by contrasting mean left and right step values; values exceeding 10% typically indicate notable dysfunction.

Visit 1 and visit 2 (which will take place 10-14 days after visit 1)
Cognitive Task Performance Cognitive Task Performance
大体时间:Visit 1 and visit 2 (which will take place 10-14 days after visit 1)

Accuracy (percentage correct) of each cognitive task. This reflects cognitive performance and is measured in both dual-task and single-task conditions.

Visit 1 and visit 2 (which will take place 10-14 days after visit 1)
Cognitive Task Performance
大体时间:Visit 1 and visit 2 (which will take place 10-14 days after visit 1)

Measure Response time (milliseconds)

Visit 1 and visit 2 (which will take place 10-14 days after visit 1)
Functional Mobility (Two-minute Walk Test)
大体时间:Visit 1 and visit 2 (which will take place 10-14 days after visit 1)

Two-minute Walk Test measures the total distance a person can walk on a flat, hard surface within two minutes. It evaluates functional mobility, submaximal endurance, and self-paced walking capacity in adults. Recorded to the nearest meter or foot using a measuring wheel, and lap count.

Visit 1 and visit 2 (which will take place 10-14 days after visit 1)
Functional Mobility (Timed Up and Go)
大体时间:Visit 1

Timed Up and Go (TUG) test measures functional mobility, dynamic balance, and fall risk by timing how fast a person stands from a chair, walks 3 meters (10 feet), turns around, walks back, and sits down. Under 10-12 seconds: Normal, independent mobility with low fall risk.12-20 seconds: Moderate risk of falling or subtle mobility issues; requires further evaluation.Over 14-20 seconds: High risk for falls; often indicates difficulty moving outside alone or a need for assistive devices.

Visit 1
Eye Tracking (Target Fixation Time)
大体时间:Visit 1 and visit 2 (which will take place 10-14 days after visit 1)

Target Fixation Time (seconds; %), The length of time the eye remains relatively still on a target to process detail, reflecting visual attention.

Visit 1 and visit 2 (which will take place 10-14 days after visit 1)
Eye Tracking (Number of fixations)
大体时间:Visit 1 and visit 2 (which will take place 10-14 days after visit 1)

Number of fixations is a core metric measuring how many times a person's eyes pause and focus on a specific area or object. High Fixation Count: indicates frequent attention on an area or element. Low Fixation Count: Means an element was quickly passed over, easily understood, or ignored.

Visit 1 and visit 2 (which will take place 10-14 days after visit 1)
Patient Reported Outcomes (Houghton Scale)
大体时间:Visit 1

The Houghton Scale assesses a person's confidence and ability in using their prosthesis safely and effectively during everyday mobility tasks. The Houghton Scale is a self-administered, 4-item questionnaire used to assess the functional use of a prosthesis by individuals with lower-limb amputations.It measures how often a patient wears their prosthesis, the types of activities they perform with it, and their perceived stability in various outdoor environments. Total scores range from 0 to 12, with higher scores indicating greater prosthesis use and independence

Visit 1
Patient Reported Outcomes (PEQ - Mobility subscale)
大体时间:Visit 1

PEQ - Mobility subscale is the The Prosthesis Evaluation Questionnaire - Mobility subscale, captures a person's self reported ability to move and perform daily activities while using their prosthesis. It uses a 5-point ordinal scale (0-4). 0: Not able or hardly able to 4: No problem or almost fully able. The total scale ranges from 0 to 48. A higher score indicates greater mobility.

Visit 1
Patient Reported Outcomes (WHODAS)
大体时间:Visit 1

WHODAS The World health organization disability assessment schedule 2.0 (WHODAS) evaluates how health conditions impact a person's functioning and participation across major life domains over the past 30 days. Items are rated on a 5-point Likert scale: None (0), Mild (1), Moderate (2), Severe (3), and Extreme or Cannot Do (4). While no universal "cut-off" exists, scores placing a patient in the top 10% of the population distribution-roughly >10 for the 12-item simple score or >41 for the 36-item version-likely indicate significant impairment.

Visit 1
Patient Reported Outcomes (Activities Specific Balance Confidence Scale)
大体时间:Visit 1

Activities Specific Balance Confidence Scale is a self-report instrument used to measure an individual's confidence in maintaining balance while performing 16 various daily activities. Unlike performance-based tests, it captures the patient's perceived ability to avoid falling or becoming unsteady.Patients rate their confidence for each item on a scale from 0% (no confidence) to 100% (complete confidence). The higher the score,the higher the function and physical activity (range > 80% high function, 50% - 80% moderate function and < 50% low function.

Visit 1
Accelerometry (Daily duration of sitting, standing, stepping)
大体时间:Between Visit 1 and 2 (which is 10-14 days after visit 1)

Daily duration (minutes) of sitting, standing, and stepping reported as an aggregate mean.

Between Visit 1 and 2 (which is 10-14 days after visit 1)
Accelerometry (Daily step count)
大体时间:Between Visit 1 and 2 (which is 10-14 days after visit 1)

Daily step count will be measured and reported as an aggregate mean.

Between Visit 1 and 2 (which is 10-14 days after visit 1)
Accelerometry (Daily walking bouts stepping cadence)
大体时间:Between Visit 1 and 2 (which is 10-14 days after visit 1)

Daily walking bouts stepping cadence will be reported as an aggregate mean

Between Visit 1 and 2 (which is 10-14 days after visit 1)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Paul Kline、Virginia Commonwealth University

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年10月25日

初级完成 (估计的)

2027年5月31日

研究完成 (估计的)

2027年5月31日

研究注册日期

首次提交

2026年9月14日

首先提交符合 QC 标准的

2026年9月17日

首次发布 (实际的)

2026年9月21日

研究记录更新

最后更新发布 (实际的)

2026年9月21日

上次提交的符合 QC 标准的更新

2026年9月17日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

其他研究编号

  • HM20030568

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅